Form D · Private Equity Fund

SV LIFE SCIENCES FUND V LP

Boston, MA · CIK 0001460732

Offering snapshot reported Mar 10, 2010 · SEC filing

Reported sold: $407M
Investors reported: 42
Minimum accepted: $0
First sale: Mar 27, 2009

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 10, 2010	Amendment	$407,226,805	No comparison	42	SEC filing
Mar 17, 2009	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Not reported
Exemptions: 06, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-129520

Source: Form D, filed Mar 10, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

SV LIFE SCIENCES FUND V, L.P.

Investment adviser: SV HEALTH INVESTORS, LLC

Gross asset value: $138M
Beneficial owners: 56
ADV minimum commitment: $1.5M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator JUNIPER SQUARE, INC SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor RSM US LLP BOSTON, Massachusetts, United States

Custodian AMERICAN STOCK TRANSFER BROOKLYN, New York, United States Related to adviser: No

Custodian BANK OF AMERICA, N.A. CHARLOTTE, North Carolina, United States Related to adviser: No

Custodian FIRST-CITIZENS BANK & TRUST COMPANY SANTA CLARA, California, United States Related to adviser: No

Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

RSM US LLP
PCAOB 49

BANK OF AMERICA, N.A.
LEI B4TYDEB6GKMZO031MB27

FIRST-CITIZENS BANK & TRUST COMPANY
LEI L9VVX1KT5TFTKS0MLF66

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

Filing source

Form ADV 2077634 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-9243054099

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
SV LIFE SCIENCES FUND V LP (this fund)	Mar 10, 2010	$407,226,805	42
SV Life Sciences Fund VI, L.P.	May 26, 2016	$273,500,000	24

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Kate Bingham	Executive
James Garvey	Executive
Lutz Giebel	Executive
Eugene D. Hill, Iii	Executive
David Milne	Executive
Michael Ross	Executive
N/A Sv Life Sciences Fund V (Gp), L.P.	Director
N/A Svlsf V, Llc	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

60 State Street Suite 3650
Boston, MA, 02109